AM6545 is a highly selective CB1 receptor antagonist that functions peripherally without crossing the blood-brain barrier (Ki=1.7 nM). By competitively inhibiting the CB1 receptors, AM6545 disrupts endocannabinoid signaling, thereby mitigating appetite stimulation and inflammatory responses without altering cAMP levels. This compound has been shown to significantly decrease food intake and body weight in murine models while improving metabolic syndrome-related renal impairment, including proteinuria, fibrosis, and insulin resistance. AM6545 is instrumental in research focused on obesity and its associated complications.
AM6545 is a highly selective CB1 receptor antagonist that functions peripherally without crossing the blood-brain barrier (Ki=1.7 nM). By competitively inhibiting the CB1 receptors, AM6545 disrupts endocannabinoid signaling, thereby mitigating appetite stimulation and inflammatory responses without altering cAMP levels. This compound has been shown to significantly decrease food intake and body weight in murine models while improving metabolic syndrome-related renal impairment, including proteinuria, fibrosis, and insulin resistance. AM6545 is instrumental in research focused on obesity and its associated complications.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
